The liver cirrhosis in animal models and in patients was observed to be improved by the systemic administration of IGF-1 (Castilla-Cortazar et al., 1997; Conchillo et al., 2005; Sobrevals et al., 2010). The gene discussed is IGF1; the disease is cirrhosis of liver.